<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38137533</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Improvement of Symptoms and Cardiac Magnetic Resonance Abnormalities in Patients with Post-Acute Sequelae of SARS-CoV-2 Cardiovascular Syndrome (PASC-CVS) after Guideline-Oriented Therapy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11123312</ELocationID><Abstract><AbstractText>Cardiac magnetic resonance (CMR) studies reported CMR abnormalities in patients with mild-moderate SARS-CoV-2 infection, suggesting ongoing myocardial inflammation. Patients (<i>n</i> = 278, 43 &#xb1; 13 years, 70.5% female) with post-acute sequelae of SARS-CoV-2 cardiovascular syndrome (PASC-CVS) were included prospectively into the Vienna POSTCOV Registry between March 2021 and March 2023 (clinicaltrials.gov NCT05398952). Clinical, laboratory, and CMR findings were recorded. Patients with abnormal CMR results were classified into isolated chronic pericardial (with/without pleural) effusion, isolated cardiac function impairment, or both (myopericarditis) groups. Medical treatment included a nonsteroidal anti-inflammatory agent (NSAID) for pericardial effusion and a condition-adapted maximal dose of heart failure (HF) treatment. Three months after medical therapy, clinical assessment and CMR were repeated in 82 patients. Laboratory analyses revealed normal hematological, inflammatory, coagulation, and cardiac biomarkers. CMR abnormalities were found in 155 patients (55.8%). Condition-adapted HF treatment led to a significant increase in the left ventricular ejection fraction (LVEF) in patients with initially reduced LVEF (from 49 &#xb1; 5% to 56 &#xb1; 4%, <i>p</i> = 0.009, <i>n</i> = 25). Low-moderate doses of NSAIDs for 3 months significantly reduced pericardial effusion (from 4/3;5.75/mm to 2/0;3/mm, median/interquartile ranges/<i>p</i> &lt; 0.001, <i>n</i> = 51). Clinical symptoms improved markedly with a decrease in CMR abnormalities, which might be attributed to the maintenance of NSAID and HF medical treatment for PASC-CVS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gy&#xf6;ngy&#xf6;si</LastName><ForeName>Mariann</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7083-2107</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasimbegovic</LastName><ForeName>Ena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3064-1277</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zlabinger</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3855-7643</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spannbauer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9819-0361</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riesenhuber</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5061-7354</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamzaraj</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2505-8554</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergler-Klein</LastName><ForeName>Jutta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hengstenberg</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8284-2994</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammerlander</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7632-9879</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kastl</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loewe</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beitzke</LastName><ForeName>Dietrich</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05398952</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>KLI 1064-B</GrantID><Agency>FWF Austrian Science Fund</Agency><Country/></Grant><Grant><GrantID>21176</GrantID><Agency>Medical-Scientific Fund of the Mayor of Vienna City</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CMR</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC-CVS</Keyword><Keyword MajorTopicYN="N">cardiac magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">chronic pericardial effusion</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myopericarditis</Keyword></KeywordList><CoiStatement>M.G. received speaker fees from Medizinische Ausstellungs- u. Werbegesellschaft, General Reinsurance AG, Merck GmbH, FomF GmbH, Medacad, and Wiener Medizinische Akademie f&#xfc;r Postgraduelle &#xc4;rztliche Fortbildung und Forschung (WMA), outside the submitted work. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38137533</ArticleId><ArticleId IdType="pmc">PMC10742066</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11123312</ArticleId><ArticleId IdType="pii">biomedicines11123312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gyongyosi M., Alcaide P., Asselbergs F.W., Brundel B., Camici G.G., Martins P.D.C., Ferdinandy P., Fontana M., Girao H., Gnecchi M., et al. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc. Res. 2023;119:336&#x2013;356. doi: 10.1093/cvr/cvac115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing C., Gluckman T.J., Bhave N.M., Allen L.A., Chung E.H., Spatz E.S., Ammirati E., Baggish A.L., Bozkurt B., Cornwell W.K., 3rd, et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 2022;79:1717&#x2013;1756. doi: 10.1016/j.jacc.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Martin S., Shchendrygina A., Hoffmann J., Ka M.M., Giokoglu E., Vanchin B., Holm N., Karyou A., Laux G.S., et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat. Med. 2022;28:2117&#x2013;2123. doi: 10.1038/s41591-022-02000-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02000-0</ArticleId><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidula M.K., Rajewska-Tabor J., Cao J.J., Kang Y., Craft J., Mei W., Chandrasekaran P.S., Clark D.E., Poenar A.M., Gorecka M., et al. Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement. JACC Cardiovasc. Imaging. 2023;16:609&#x2013;624. doi: 10.1016/j.jcmg.2022.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.10.021</ArticleId><ArticleId IdType="pmc">PMC9833283</ArticleId><ArticleId IdType="pubmed">36752429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira V.M., Plein S., Wong T.C., Tao Q., Raisi-Estabragh Z., Jain S.S., Han Y., Ojha V., Bluemke D.A., Hanneman K., et al. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: Recommendations by the Society for Cardiovascular Magnetic Resonance. J. Cardiovasc. Magn. Reason. 2023;25:21. doi: 10.1186/s12968-023-00933-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-023-00933-0</ArticleId><ArticleId IdType="pmc">PMC10041524</ArticleId><ArticleId IdType="pubmed">36973744</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Gaita F., LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA. 2015;314:1498&#x2013;1506. doi: 10.1001/jama.2015.12763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.12763</ArticleId><ArticleId IdType="pubmed">26461998</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley B.J.R., Harrison S.L., Fazio-Eynullayeva E., Underhill P., Lane D.A., Lip G.Y.H. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur. J. Clin. Investig. 2021;51:e13679. doi: 10.1111/eci.13679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13679</ArticleId><ArticleId IdType="pmc">PMC8646627</ArticleId><ArticleId IdType="pubmed">34516657</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitiku T.Y., Heidenreich P.A. A small pericardial effusion is a marker of increased mortality. Am. Heart J. 2011;161:152&#x2013;157. doi: 10.1016/j.ahj.2010.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2010.10.007</ArticleId><ArticleId IdType="pubmed">21167348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavada J., Dixon W.G., Askling J., EULAR Study Group on Longitudinal Observational Registers and Drug Studies Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: A EULAR extension of STROBE guidelines based on experience from biologics registries. Ann. Rheum. Dis. 2014;73:628. doi: 10.1136/annrheumdis-2013-204102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204102</ArticleId><ArticleId IdType="pubmed">24058015</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera J.E., Niehaus W.N., Whiteson J., Azola A., Baratta J.M., Fleming T.K., Kim S.Y., Naqvi H., Sampsel S., Silver J.K., et al. Response to letter to the editor regarding &#x201c;Multi-Disciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in patients with Post-Acute sequelae of SARS-CoV-2 infection (PASC)&#x201d;. PM&amp;R. 2021;13:1439&#x2013;1440. doi: 10.1002/pmrj.12719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12719</ArticleId><ArticleId IdType="pmc">PMC8662053</ArticleId><ArticleId IdType="pubmed">34617402</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslacher H., Gerner M., Hofer P., Jurkowitsch A., Hainfellner J., Kain R., Wagner O.F., Perkmann T. Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank. Biopreserv. Biobank. 2018;16:477&#x2013;482. doi: 10.1089/bio.2018.0032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2018.0032</ArticleId><ArticleId IdType="pmc">PMC6308288</ArticleId><ArticleId IdType="pubmed">30335475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer C.M., Barkhausen J., Bucciarelli-Ducci C., Flamm S.D., Kim R.J., Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J. Cardiovasc. Magn. Reason. 2020;22:17. doi: 10.1186/s12968-020-00607-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00607-1</ArticleId><ArticleId IdType="pmc">PMC7038611</ArticleId><ArticleId IdType="pubmed">32089132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelle S., Bucciarelli-Ducci C., Judd R.M., Kwong R.Y., Simonetti O., Plein S., Raimondi F., Weinsaft J.W., Wong T.C., Carr J. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection. J. Cardiovasc. Magn. Reason. 2020;22:61. doi: 10.1186/s12968-020-00656-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00656-6</ArticleId><ArticleId IdType="pmc">PMC7467754</ArticleId><ArticleId IdType="pubmed">32878639</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz-Menger J., Bluemke D.A., Bremerich J., Flamm S.D., Fogel M.A., Friedrich M.G., Kim R.J., von Knobelsdorff-Brenkenhoff F., Kramer C.M., Pennell D.J., et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance&#x2014;2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J. Cardiovasc. Magn. Reason. 2020;22:19. doi: 10.1186/s12968-020-00610-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00610-6</ArticleId><ArticleId IdType="pmc">PMC7066763</ArticleId><ArticleId IdType="pubmed">32160925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kammerlander A.A., Marzluf B.A., Zotter-Tufaro C., Aschauer S., Duca F., Bachmann A., Knechtelsdorfer K., Wiesinger M., Pfaffenberger S., Greiser A., et al. T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication. JACC Cardiovasc. Imaging. 2016;9:14&#x2013;23. doi: 10.1016/j.jcmg.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2015.11.002</ArticleId><ArticleId IdType="pubmed">26684970</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler Y., Charron P. The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. Eur. Heart J. 2015;36:2873&#x2013;2874. doi: 10.1093/eurheartj/ehv318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv318</ArticleId><ArticleId IdType="pubmed">26547486</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiabrando J.G., Bonaventura A., Vecchie A., Wohlford G.F., Mauro A.G., Jordan J.H., Grizzard J.D., Montecucco F., Berrocal D.H., Brucato A., et al. Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020;75:76&#x2013;92. doi: 10.1016/j.jacc.2019.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.11.021</ArticleId><ArticleId IdType="pubmed">31918837</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Bohm M., Burri H., Butler J., Celutkiene J., Chioncel O., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42:3599&#x2013;3726. doi: 10.1093/eurheartj/ehab368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., Deswal A., Drazner M.H., Dunlay S.M., Evers L.R., et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2022;79:1757&#x2013;1780. doi: 10.1016/j.jacc.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.011</ArticleId><ArticleId IdType="pubmed">35379504</ArticleId></ArticleIdList></Reference><Reference><Citation>Massaro M.G., Rigante D., Sicignano L.L., Verrecchia E., De Vito F., Gasbarrini A., Manna R. Therapeutic management of idiopathic recurrent serositis: A retrospective study. Eur. Rev. Med. Pharmacol. Sci. 2020;24:3352&#x2013;3359. doi: 10.26355/eurrev_202003_20703.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202003_20703</ArticleId><ArticleId IdType="pubmed">32271453</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishijima Y., Hader S.N., Beyer A.M. Differential impacts of COVID-19 variants on human microvascular function. Cardiovasc. Res. 2023;119:e115&#x2013;e117. doi: 10.1093/cvr/cvad006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvad006</ArticleId><ArticleId IdType="pmc">PMC10236003</ArticleId><ArticleId IdType="pubmed">36708228</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymans S., Cooper L.T. Myocarditis after COVID-19 mRNA vaccination: Clinical observations and potential mechanisms. Nat. Rev. Cardiol. 2022;19:75&#x2013;77. doi: 10.1038/s41569-021-00662-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00662-w</ArticleId><ArticleId IdType="pmc">PMC8656440</ArticleId><ArticleId IdType="pubmed">34887571</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen S.E., Friedrich M.G., Leiner T., Elias M.D., Ferreira V.M., Fenski M., Flamm S.D., Fogel M., Garg R., Halushka M.K., et al. Cardiovascular Magnetic Resonance for Patients With COVID-19. JACC Cardiovasc. Imaging. 2022;15:685&#x2013;699. doi: 10.1016/j.jcmg.2021.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.08.021</ArticleId><ArticleId IdType="pmc">PMC8514168</ArticleId><ArticleId IdType="pubmed">34656482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy C.W., Fonarow G.C. Coronavirus Disease 2019 (COVID-19) and the Heart&#x2014;Is Heart Failure the Next Chapter? JAMA Cardiol. 2020;5:1216&#x2013;1217. doi: 10.1001/jamacardio.2020.3575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3575</ArticleId><ArticleId IdType="pubmed">32730614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira V.M., Schulz-Menger J., Holmvang G., Kramer C.M., Carbone I., Sechtem U., Kindermann I., Gutberlet M., Cooper L.T., Liu P., et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J. Am. Coll. Cardiol. 2018;72:3158&#x2013;3176. doi: 10.1016/j.jacc.2018.09.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy E., Leonard M., Mak R., Liao J., Fulzele A., Bennett E.J. ZNF598 and RACK1 Regulate Mammalian Ribosome-Associated Quality Control Function by Mediating Regulatory 40S Ribosomal Ubiquitylation. Mol. Cell. 2017;65:751&#x2013;760.e4. doi: 10.1016/j.molcel.2016.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.12.026</ArticleId><ArticleId IdType="pmc">PMC5321136</ArticleId><ArticleId IdType="pubmed">28132843</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada I., Gonzalez-Moreno J., Roda N., Ventayol L., Borjas Y., Dominguez F.J., Fernandez-Baca V., Garcia-Gasalla M., Payeras A. Polyserositis: A diagnostic challenge. Intern. Med. J. 2018;48:982&#x2013;987. doi: 10.1111/imj.13966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.13966</ArticleId><ArticleId IdType="pubmed">29761620</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E., Shanghavi S., Viner T. Polyserositis secondary to COVID-19: The diagnostic dilemma. BMJ Case Rep. 2021;14:1439&#x2013;1440. doi: 10.1136/bcr-2021-243880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-243880</ArticleId><ArticleId IdType="pmc">PMC8477236</ArticleId><ArticleId IdType="pubmed">34580128</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmonaco A.G., Carpino A., Raffaldi I., Pruccoli G., Garrone E., Del Monte F., Riboldi L., Licciardi F., Urbino A.F., Parodi E. First diagnosis of multisystem inflammatory syndrome in children (MIS-C): An analysis of PoCUS findings in the ED. Ultrasound J. 2021;13:41. doi: 10.1186/s13089-021-00243-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13089-021-00243-5</ArticleId><ArticleId IdType="pmc">PMC8424151</ArticleId><ArticleId IdType="pubmed">34495434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazaros G., Imazio M., Tsioufis P., Lazarou E., Vlachopoulos C., Tsioufis C. Chronic Pericardial Effusion: Causes and Management. Can. J. Cardiol. 2023;39:1121&#x2013;1131. doi: 10.1016/j.cjca.2023.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.02.003</ArticleId><ArticleId IdType="pubmed">36773704</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F., Stegemann M., Agarwal A., Agoritsas T., Siemieniuk R., Rochwerg B., Bartoszko J., Askie L., Macdonald H., Al-Maslamani M., et al. A living WHO guideline on drugs to prevent COVID-19. BMJ. 2021;372:n526. doi: 10.1136/bmj.n526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n526</ArticleId><ArticleId IdType="pubmed">33649077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatayama Y., Hashimoto Y., Motokura T. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy. J. Int. Med. Res. 2020;48:300060520972880. doi: 10.1177/0300060520972880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060520972880</ArticleId><ArticleId IdType="pmc">PMC7708703</ArticleId><ArticleId IdType="pubmed">33249964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Song J., Liu H., Zheng H., Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci. Rep. 2021;11:10902. doi: 10.1038/s41598-021-90351-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyongyosi M., Lukovic D., Mester-Tonczar J., Zlabinger K., Einzinger P., Spannbauer A., Schweiger V., Schefberger K., Samaha E., Bergler-Klein J., et al. Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome. NPJ Vaccines. 2023;8:145. doi: 10.1038/s41541-023-00739-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-023-00739-2</ArticleId><ArticleId IdType="pmc">PMC10541897</ArticleId><ArticleId IdType="pubmed">37773184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yar A., Uusitalo V., Vaara S.M., Holmstrom M., Vuorinen A.M., Helio T., Paakkanen R., Kivisto S., Syvaranta S., Hastbacka J. Cardiac magnetic resonance -detected myocardial injury is not associated with long-term symptoms in patients hospitalized due to COVID-19. PLoS ONE. 2023;18:e0282394. doi: 10.1371/journal.pone.0282394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0282394</ArticleId><ArticleId IdType="pmc">PMC9994679</ArticleId><ArticleId IdType="pubmed">36888600</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>